We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

143 hedge funds and large institutions have $656M invested in Immunogen Inc in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more call options, than puts

Call options by funds: $5.14M | Put options by funds: $1.8M

59% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 34

6% less funds holding

Funds holding: 152 → 143 (-9)

27% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 26

38% less capital invested

Capital invested by funds: $1.05B → $656M (-$397M)

Holders
143
Holders Change
-9
Holders Change %
-5.92%
% of All Funds
3.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
54
Reduced
34
Closed
26
Calls
$5.14M
Puts
$1.8M
Net Calls
+$3.34M
Net Calls Change
+$2.91M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.74M
2
Fisher Asset Management
Fisher Asset Management
Washington
+$2.07M
3
NC
Nexthera Capital
New York
+$1.93M
4
ClearBridge Investments
ClearBridge Investments
New York
+$1.88M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.62M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.76M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.52M
3
Prudential Financial
Prudential Financial
New Jersey
-$2.78M
4
OAM
Oxford Asset Management
United Kingdom
-$2.36M
5
CIP
Convergence Investment Partners
Florida
-$1.9M

IMGN Hedge Fund Activity: Q1 2016 in Review

143 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2016, worth a combined $656M — down 38% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of IMGN and 19 opened new positions — a net loss of 7 holders — while 34 trimmed existing stakes and 54 added.

The largest buyer was Vanguard Group, adding an estimated $2.74M. The largest seller was Fidelity Investments, cutting an estimated $4.76M.

  • 143 institutional investors held Immunogen Inc (IMGN) as of Q1 2016, down from 152 in Q4 2015.
  • Funds reported $656M of Immunogen Inc stock for Q1 2016, down 38% quarter-over-quarter.
  • 19 funds opened new Immunogen Inc positions in Q1 2016 and 26 closed out, a net change of -7 holders.
  • The largest Immunogen Inc buyer in Q1 2016 was Vanguard Group, an estimated $2.74M added.
  • The largest Immunogen Inc seller in Q1 2016 was Fidelity Investments, an estimated $4.76M sold.

Based on aggregated 13F filings for Q1 2016.